Stocks Crossing The 13 Week Moving Average <$10.01 Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Stocks Crossing The 13 Week Moving Average <$10.01

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: WhatsUpWithThat who wrote (12737)	9/17/2003 8:27:13 AM
From: Jibacoa	Read Replies (1) of 13094

Investor Alert Introgen Therapeutics, Inc. has added a News Release to its Investor Relations web site. Title: Introgen Receives FDA Fast Track Designation for Advexin(R) Date: 9/17/2003 7:00:00 AM For a complete listing of our News Releases visit: ir.ccbn.com And that is for Advexin. Wait when they get it for INGN 241.<g> The stock is up $2.40 in "Pre-Markey".<g> Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next